Novel genome polymorphisms in BCG vaccine strains and impact on efficacy

BMC Genomics

Volumn 9, Issue , 2008, Pages

  Leung, Andrea S ^a   Tran, Vanessa ^a   Wu, Zuowei ^b   Yu, Xuping ^c   Alexander, David C ^a   Gao, George Fu ^b   Zhu, Baoli ^b   Liu, Jun ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b INSTITUTE OF MICROBIOLOGY   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BCG VACCINE; PHOP PROTEIN; PROTEIN PHOR; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; BACTERIAL CELL WALL; BACTERIAL GENETICS; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BCG VACCINATION; CONTROLLED STUDY; DNA SEQUENCE; DRUG EFFICACY; GENE DELETION; GENE DUPLICATION; GENE LOCUS; GENETIC POLYMORPHISM; IMMUNOGENICITY; MYCOBACTERIUM BOVIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; STRAIN DIFFERENCE; TUBERCULIN TEST; DNA MICROARRAY; GENETICS; GENOME; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; TREATMENT OUTCOME; TUBERCULOSIS; VIRULENCE;

MYCOBACTERIUM BOVIS;

BCG VACCINE; GENOME; GENOME, BACTERIAL; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; POLYMORPHISM, GENETIC; TREATMENT OUTCOME; TUBERCULOSIS; VIRULENCE;

EID: 52749099238     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-9-413     Document Type: Article

References (76)

1. Colditz GA Berkey CS Mosteller F Brewer TF Wilson ME Burdick E Fineberg HV The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: Meta-analyses of the published literature Pediatrics 1995, 96:29-35. 7596718
2. Trunz BB Fine P Dye C Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: A meta-analysis and assessment of cost-effectiveness Lancet 2006, 367:1173-1180. 10.1016/ S0140-6736(06)68507-3 16616560
3. Zodpey SP Protective effect of bacillus Calmette Guerin (BCG) vaccine in the prevention of leprosy: A meta-analysis Indian J Dermatol Venereol Leprol 2007, 73:86-93. 17456912
4. Brewer TF Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature Clin Infect Dis 2000. 31(Suppl 3):S64-S67. 10.1086/314072 11010824
5. Colditz GA Brewer TF Berkey CS Wilson ME Burdick E Fineberg HV Mosteller F Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature JAMA 1994, 271:698-702. 10.1001/jama.271.9.698 8309034
6. Behr MA BCG-different strains, different vaccines? Lancet Infect Dis 2002, 2:86-92. 10.1016/S1473-3099(02)00182-2 11901655
7. Brandt L Feino CJ Weinreich OA Chilima B Hirsch P Appelberg R Andersen P Failure of the Mycobacterium bovis BCG vaccine: Some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis Infect Immun 2002, 70:672-678. 127715 11796598 10.1128/IAI.70.2.672-678.2002
8. Comstock GW Field trials of tuberculosis vaccines: How could we have done them better? Control Clin Trials 1994, 15:247-276. 10.1016/ 0197-2456(94)90042-6 7956266
9. Demangel C Garnier T Rosenkrands I Cole ST Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens Infect Immun 2005, 73:2190-2196. 1087454 15784562 10.1128/ IAI.73.4.2190-2196.2005
10. Bonah C The 'experimental stable' of the BCG vaccine: Safety, efficacy, proof, and standards, 1921-1933 Stud Hist Philos Biol Biomed Sci 2005, 36:696-721. 10.1016/j.shpsc.2005.09.003 16337557
11. Lind A The Swedish strain of BCG Tubercle 1983, 64:223-224. 10.1016/ 0041-3879(83)90019-3 6636307
12. Osborn TW Changes in BCG strains Tubercle 1983, 64:1-13. 10.1016/ 0041-3879(83)90044-2 6342243
13. Corbel MJ Fruth U Griffiths E Knezevic I Report on a WHO consultation on the characterisation of BCG strains, Imperial College, London 15-16 December 2003 Vaccine 2004, 22:2675-2680. 10.1016/j.vaccine.2004.01.050 15309814
14. Anonymous BCG vaccine. WHO position paper Wkly Epidemiol Rec 2004, 79:27-38. 14768305
15. Brewer TF Colditz GA Relationship between bacille Calmette-Guerin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis Clin Infect Dis 1995, 20:126-135. 7727638
16. Gupta KC Effect of freeze-drying on the colony morphology of various daughter strains of BCG J Biol Stand 1975, 3:349-352. 10.1016/ 0092-1157(75)90059-1 1102547
17. Brosch R Gordon SV Billault A Garnier T Eiglmeier K Soravito C Barrell BG Cole ST Use of a Mycobacterium tuberculosis H37Rv bacterial artificial chromosome library for genome mapping, sequencing, and comparative genomics Infect Immun 1998, 66:2221-2229. 108185 9573111
18. Mahairas GG Sabo PJ Hickey MJ Singh DC Stover CK Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis J Bacteriol 1996, 178:1274-1282. 177799 8631702
19. Philipp WJ Nair S Guglielmi G Lagranderie M Gicquel B Cole ST Physical mapping of Mycobacterium bovis BCG pasteur reveals differences from the genome map of Mycobacterium tuberculosis H37Rv and from M. bovis Microbiology 1996, 142(Pt 11):3135-3145. 8969511
20. Behr MA Wilson MA Gill WP Salamon H Schoolnik GK Rane S Small PM Comparative genomics of BCG vaccines by whole-genome DNA microarray Science 1999, 284:1520-1523. 10.1126/science.284.5419.1520 10348738
21. Brosch R Gordon SV Buchrieser C Pym AS Garnier T Cole ST Comparative genomics uncovers large tandem chromosomal duplications in Mycobacterium bovis BCG Pasteur Yeast 2000, 17:111-123. 10.1002/ 1097-0061(20000630)17:2<111::AID-YEA17>3.0.CO;2-G 10900457
22. Mostowy S Tsolaki AG Small PM Behr MA The in vitro evolution of BCG vaccines Vaccine 2003, 21:4270-4274. 10.1016/S0264-410X(03)00484-5 14505909
23. Behr MA Small PM A historical and molecular phylogeny of BCG strains Vaccine 1999, 17:915-922. 10.1016/S0264-410X(98)00277-1 10067698
24. Brosch R Gordon SV Garnier T Eiglmeier K Frigui W Valenti P Dos SS Duthoy S Lacroix C Garcia-Pelayo C Inwald JK Golby P Garcia JN Hewinson RG Behr MA Quail MA Churcher C Barrell BG Parkhill J Cole ST Genome plasticity of BCG and impact on vaccine efficacy Proc Natl Acad Sci USA 2007, 104:5596-5601. 1838518 17372194 10.1073/pnas.0700869104
25. Salamon H Kato-Maeda M Small PM Drenkow J Gingeras TR Detection of deleted genomic DNA using a semiautomated computational analysis of GeneChip data Genome Res 2000, 10:2044-2054. 313082 11116098 10.1101/ gr.GR-1529R
26. Frigui W Bottai D Majlessi L Monot M Josselin E Brodin P Garnier T Gicquel B Martin C Leclerc C Cole ST Brosch R Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP PLoS Pathog 2008, 4:e33. 2242835 18282096 10.1371/journal.ppat.0040033
27. Manjunatha UH Boshoff H Dowd CS Zhang L Albert TJ Norton JE Daniels L Dick T Pang SS Barry CE Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis Proc Natl Acad Sci USA 2006, 103:431-436. 1326169 16387854 10.1073/pnas.0508392103
28. Wong CW Albert TJ Vega VB Norton JE Cutler DJ Richmond TA Stanton LW Liu ET Miller LD Tracking the evolution of the SARS coronavirus using high-throughput, high-density resequencing arrays Genome Res 2004, 14:398-405. 353227 14993206 10.1101/gr.2141004
29. Cole ST Brosch R Parkhill J Garnier T Churcher C Harris D Gordon SV Eiglmeier K Gas S Barry CE Tekaia F Badcock K Basham D Brown D Chillingworth T Connor R Davies R Devlin K Feltwell T Gentles S Hamlin N Holroyd S Hornsby T Jagels K Krogh A McLean J Moule S Murphy L Oliver K Osborne J Quail MA Rajandream MA Rogers J Rutter S Seeger K Skelton J Squares R Squares S Sulston JE Taylor K Whitehead S Barrell BG Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence Nature 1998, 393:537-544. 10.1038/31159 9634230
30. Garnier T Eiglmeier K Camus JC Medina N Mansoor H Pryor M Duthoy S Grondin S Lacroix C Monsempe C Simon S Harris B Atkin R Doggett J Mayes R Keating L Wheeler PR Parkhill J Barrell BG Cole ST Gordon SV Hewinson RG The complete genome sequence of Mycobacterium bovis Proc Natl Acad Sci USA 2003, 100:7877-7882. 164681 12788972 10.1073/pnas.1130426100
31. Onwueme KC Vos CJ Zurita J Ferreras JA Quadri LE The dimycocerosate ester polyketide virulence factors of mycobacteria Prog Lipid Res 2005, 44:259-302. 10.1016/j.plipres.2005.07.001 16115688
32. Cox JS Chen B McNeil M Jacobs WRJ Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice Nature 1999, 402:79-83. 10.1038/47042 10573420
33. Hotter GS Wards BJ Mouat P Besra GS Gomes J Singh M Bassett S Kawakami P Wheeler PR de Lisle GW Collins DM Transposon mutagenesis of Mb0100 at the ppe1-nrp locus in Mycobacterium bovis disrupts phthiocerol dimycocerosate (PDIM) and glycosylphenol-PDIM biosynthesis, producing an avirulent strain with vaccine properties at least equal to those of M. bovis BCG J Bacteriol 2005, 187:2267-2277. 1065232 15774869 10.1128/ JB.187.7.2267-2277.2005
34. Reed MB Domenech P Manca C Su H Barczak AK Kreiswirth BN Kaplan G Barry CE A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response Nature 2004, 431:84-87. 10.1038/nature02837 15343336
35. Chen JM Islam ST Ren H Liu J Differential productions of lipid virulence factors among BCG vaccine strains and implications on BCG safety Vaccine 2007, 25:8114-8122. 17954004
36. Rauzier J Gormley E Gutierrez MC Kassa-Kelembho E Sandall LJ Dupont C Gicquel B Murray A A novel polymorphic genetic locus in members of the Mycobacterium tuberculosis complex Microbiology 1999, 145(Pt 7):1695-1701. 10439408
37. Abdallah AM Gey vPN Champion PA Cox J Luirink J Vandenbroucke-Grauls CM Appelmelk BJ Bitter W Type VII secretion-mycobacteria show the way Nat Rev Microbiol 2007, 5:883-891. 10.1038/nrmicro1773 17922044
38. Geiman DE Raghunand TR Agarwal N Bishai WR Differential gene expression in response to exposure to antimycobacterial agents and other stress conditions among seven Mycobacterium tuberculosis whiB-like genes Antimicrob Agents Chemother 2006, 50:2836-2841. 1538666 16870781 10.1128/ AAC.00295-06
39. Singh A Guidry L Narasimhulu KV Mai D Trombley J Redding KE Giles GI Lancaster JRJ Steyn AJ Mycobacterium tuberculosis WhiB3 responds to O2 and nitric oxide via its [4Fe-4S] cluster and is essential for nutrient starvation survival Proc Natl Acad Sci USA 2007 104 11562 11567 1906726 17609386 10.1073/pnas.0700490104
40. Steyn AJ Collins DM Hondalus MK Jacobs WRJ Kawakami RP Bloom BR Mycobacterium tuberculosis WhiB3 interacts with RpoV to affect host survival but is dispensable for in vivo growth Proc Natl Acad Sci USA 2002, 99:3147-3152. 122487 11880648 10.1073/pnas.052705399
41. Parish T Smith DA Kendall S Casali N Bancroft GJ Stoker NG Deletion of two-component regulatory systems increases the virulence of Mycobacterium tuberculosis Infect Immun 2003, 71:1134-1140. 148821 12595424 10.1128/IAI.71.3.1134-1140.2003
42. Abdallah AM Verboom T Hannes F Safi M Strong M Eisenberg D Musters RJ Vandenbroucke-Grauls CM Appelmelk BJ Luirink J Bitter W A specific secretion system mediates PPE41 transport in pathogenic mycobacteria Mol Microbiol 2006, 62:667-679. 10.1111/j.1365-2958.2006.05409.x 17076665
43. Gey vPN Sampson SL Lee H Kim Y van Helden PD Warren RM Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions BMC Evol Biol 2006, 6:95. 1660551 17105670 10.1186/ 1471-2148-6-95
44. Pruchova J Mara M Mohelska H Sir Z Galliova J Some biological, biochemical and morphological changes and their correlations in selected BCG vaccine strains J Biol Stand 1976, 4:319-327. 10.1016/ S0092-1157(76)80016-9 791950
45. Oettinger T Jorgensen M Ladefoged A Haslov K Andersen P Development of the Mycobacterium bovis BCG vaccine: Review of the historical and biochemical evidence for a genealogical tree Tuber Lung Dis 1999, 79:243-250. 10.1054/tuld.1999.0206 10692993
46. Lee JS Krause R Schreiber J Mollenkopf HJ Kowall J Stein R Jeon BY Kwak JY Song MK Patron JP Jorg S Roh K Cho SN Kaufmann SH Mutation in the transcriptional regulator PhoP contributes to avirulence of Mycobacterium tuberculosis H37Ra strain Cell Host Microbe 2008, 3:97-103. 10.1016/j.chom.2008.01.002 18312844
47. Martin C Williams A Hernandez-Pando R Cardona PJ Gormley E Bordat Y Soto CY Clark SO Hatch GJ Aguilar D Ausina V Gicquel B The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs Vaccine 2006, 24:3408-3419. 10.1016/j.vaccine.2006.03.017 16564606
48. Walters SB Dubnau E Kolesnikova I Laval F Daffe M Smith I The Mycobacterium tuberculosis PhoPR two-component system regulates genes essential for virulence and complex lipid biosynthesis Mol Microbiol 2006, 60:312-330. 10.1111/j.1365-2958.2006.05102.x 16573683
49. Fomukong NG Dale JW Osborn TW Grange JM Use of gene probes based on the insertion sequence IS986 to differentiate between BCG vaccine strains J Appl Bacteriol 1992, 72:126-133. 1313411
50. Soto CY Menendez MC Perez E Samper S Gomez AB Garcia MJ Martin C IS6110 mediates increased transcription of the phoP virulence gene in a multidrug-resistant clinical isolate responsible for tuberculosis outbreaks J Clin Microbiol 2004, 42:212-219. 321672 14715755 10.1128/ JCM.42.1.212-219.2004
51. Rivero A Marquez M Santos J Pinedo A Sanchez MA Esteve A Samper S Martin C High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain B Clin Infect Dis 2001, 32:159-161. 10.1086/317547 11112675
52. Gupta S Sinha A Sarkar D Transcriptional autoregulation by Mycobacterium tuberculosis PhoP involves recognition of novel direct repeat sequences in the regulatory region of the promoter FEBS Lett 2006, 580:5328-5338. 10.1016/j.febslet.2006.09.004 16979633
53. Sinha A Gupta S Bhutani S Pathak A Sarkar D PhoP-PhoP interaction at adjacent PhoP binding sites is influenced by protein phosphorylation J Bacteriol 2008, 190:1317-1328. 2238199 18065544 10.1128/JB.01074-07
54. Wang S Engohang-Ndong J Smith I Structure of the DNA-binding domain of the response regulator PhoP from Mycobacterium tuberculosis Biochemistry 2007, 46:14751-14761. 10.1021/bi700970a 18052041
55. Behr MA Sherman DR Mycobacterial virulence and specialized secretion: same story, different ending Nat Med 2007, 13:286-287. 10.1038/ nm0307-286 17342140
56. Pym AS Brodin P Majlessi L Brosch R Demangel C Williams A Griffiths KE Marchal G Leclerc C Cole ST Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis Nat Med 2003, 9:533-539. 10.1038/nm859 12692540
57. Lagranderie MR Balazuc AM Deriaud E Leclerc CD Gheorghiu M Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains Infect Immun 1996, 64:1-9. 173719 8557324
58. Milstien JB Gibson JJ Quality control of BCG vaccine by WHO: A review of factors that may influence vaccine effectiveness and safety Bull World Health Organ 1990, 68:93-108. 2189588
59. Isabel O Gomez AB Kremer K de Haas P Garcia MJ Martin C van Soolingen D Mapping of IS6110 insertion sites in Mycobacterium bovis isolates in relation to adaptation from the animal to human host Vet Microbiol 2008, 129:333-341. 10.1016/j.vetmic.2007.11.038 18207337
60. Lotte A Wasz-Hockert O Poisson N Dumitrescu N Verron M Couvet E BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics Adv Tuberc Res 1984, 21:107-193. 6475644
61. Chesne-Seck ML Barilone N Boudou F Gonzalo AJ Kolattukudy PE Martin C Cole ST Gicquel B Gopaul DN Jackson M A point mutation in the two-component regulator PhoP-PhoR accounts for the absence of polyketide-derived acyltrehaloses but not that of phthiocerol dimycocerosates in Mycobacterium tuberculosis H37Ra J Bacteriol 2008, 190:1329-1334. 2238218 18065542 10.1128/JB.01465-07
62. Gonzalo AJ Maia C Ferrer NL Barilone N Laval F Soto CY Winter N Daffe M Gicquel B Martin C Jackson M The virulence-associated two-component PhoP-PhoR system controls the biosynthesis of polyketide-derived lipids in Mycobacterium tuberculosis J Biol Chem 2006, 281:1313-1316. 16326699
63. Vallishayee RS Shashidhara AN Bunch-Christensen K Guld J Tuberculin sensitivity and skin lesions in children after vaccination with 11 different BCG strains Bull World Health Organ 1974, 51:489-494. 4549499
64. Ladefoged A Bunch-Christensen K Guld J Tuberculin sensitivity in guinea-pigs after vaccination with varying doses of BCG of 12 different strains Bull World Health Organ 1976, 53:435-443. 1086736
65. Lotte A Wasz-Hockert O Poisson N Engbaek H Landmann H Quast U Andrasofszky B Lugosi L Vadasz I Mihailescu P Second IUATLD study on complications induced by intradermal BCG-vaccination Bull Int Union Tuberc Lung Dis 1988, 63:47-59. 3066422
66. Asensio JA Arbues A Perez E Gicquel B Martin C Live tuberculosis vaccines based on phoP mutants: A step towards clinical trials Expert Opin Biol Ther 2008, 8:201-211. 10.1517/14712598.8.2.201 18194076
67. Horwitz MA Lee BW Dillon BJ Harth G Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis Proc Natl Acad Sci USA 1995, 92:1530-1534. 42553 7878014 10.1073/pnas.92.5.1530
68. Horwitz MA Harth G Dillon BJ Maslesa-Galic S Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model Proc Natl Acad Sci USA 2000, 97:13853-13858. 17665 11095745 10.1073/pnas.250480397
69. Horwitz MA Harth G A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis Infect Immun 2003, 71:1672-1679. 152073 12654780 10.1128/IAI.71.4.1672-1679.2003
70. Horwitz MA Harth G Dillon BJ Maslesa-Galic S Enhancing the protective efficacy of Mycobacterium bovis BCG vaccination against tuberculosis by boosting with the Mycobacterium tuberculosis major secretory protein Infect Immun 2005, 73:4676-4683. 1201189 16040980 10.1128/ IAI.73.8.4676-4683.2005
71. Horwitz MA Harth G Dillon BJ Maslesa-Galic S A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG Vaccine 2006, 24:1593-1600. 10.1016/j.vaccine.2005.10.002 16257099
72. Skeiky YA Sadoff JC Advances in tuberculosis vaccine strategies Nat Rev Microbiol 2006, 4:469-476. 10.1038/nrmicro1419 16710326
73. Collins DM de Lisle GW Aldwell FE Buddle BM A new attenuated Mycobacterium bovis vaccine protects brushtail possums (Trichosurus vulpecula) against experimental tuberculosis infection Vaccine 2007, 25:4659-4664. 10.1016/j.vaccine.2007.04.014 17498852
74. Nuwaysir EF Huang W Albert TJ Singh J Nuwaysir K Pitas A Richmond T Gorski T Berg JP Ballin J McCormick M Norton J Pollock T Sumwalt T Butcher L Porter D Molla M Hall C Blattner F Sussman MR Wallace RL Cerrina F Green RD Gene expression analysis using oligonucleotide arrays produced by maskless photolithography Genome Res 2002, 12:1749-1755. 187555 12421762 10.1101/gr.362402
75. Albert TJ Norton J Ott M Richmond T Nuwaysir K Nuwaysir EF Stengele KP Green RD Light-directed 5′→3′ synthesis of complex oligonucleotide microarrays Nucleic Acids Res 2003, 31:e35. 152820 12655023 10.1093/nar/gng035
76. Molla M Shavlik J Richmond T Smith S A self-tuning method for one-chip SNP identification Proc IEEE Comput Syst Bioinform Conf 2004:69-79. 16448001